Navigation Links
IDRI and Medicago to present data at the World Vaccine Congress
Date:4/9/2013

t. Medicago also intends to expand development into other areas such as biosimilars and biodefense products where the benefits of our technologies can make a significant difference. Additional information about Medicago is available at www.medicago.com.  

About NanoPass Technologies Ltd.
NanoPass is the developer of MicronJet600™, an FDA-registered intradermal microneedles device. NanoPass has concluded the world's first intradermal pandemic (H1N1) flu vaccine clinical study and additional seasonal flu studies, demonstrating equivalent or superior immunogenicity to standard intramuscular delivery using only 20% of the dose.

Forward Looking Statements

This news release includes certain forward-looking statements or forward-looking information for the purposes of applicable securities laws and such statements and information are based upon current expectations, which involve

risks and uncertainties associated with Medicago's business and the environment in which the business operates. Any statements contained herein that are not statements of historical facts may be deemed to be forward-looking, including those identified by the expressions "anticipate", "believe", "plan", "estimate", "expect", "intend", and similar expressions to the extent they relate to Medicago or its management. The forward-looking statements are not historical facts, but reflect Medicago's current expectations

regarding future results or events. Such statements include but are not limited to statements about the collaboration with IDRI and the Phase I clinical trial.  These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations, including the matters discussed under "Risk Factors and Uncertainties" in Medicago's Annual Information Form filed on March 28, 2013,
'/>"/>

SOURCE Infectious Disease Research Institute (IDRI)
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. NewGen Therapeutics Presents Data on NT-113, A Novel Pan-ErbB Inhibitor, at American Association of Cancer Research
2. Exosome Presents Late-Breaking Study Demonstrating Ability to Profile RNA from Archived Clinical Trial Blood Samples at 2013 American Association of Cancer Research Annual Meeting
3. Sorrento Therapeutics, Inc. and IGDRASOL Announce Presentation on Non-Biologic Nanoparticle paclitaxel (NBN-Pac) Formulations for the Treatment of Solid Tumors at the Nanomedicine 2013 Meeting in Barcelona, Spain
4. Positive Preclinical Data for NKTR-214, an Investigational Cancer Immunotherapy Targeting the IL-2 Receptor Complex, Presented at AACR Annual Meeting 2013
5. Cardium Presents Year-End 2012 Financial Results And Recent Developments
6. Vanda Pharmaceuticals to Present at the BioCentury Future Leaders in the Biotech Industry Conference
7. Pharmagen Presents to North Carolina General Assembly at N.C. Bios Legislative Breakfast
8. Cerulean Pharma to Present Data on CRLX101s HIF-1a Inhibition at the American Association for Cancer Research Annual Meeting
9. NewLink Genetics Presents Preclinical Data on NLG919, a New Drug Candidate from a Novel Class of IDO Pathway Inhibitors for the Treatment of Cancer
10. Dr. Kevin Foley to Present DiscGenics Recent Findings at the Lumbar Spine Research Societys Annual Meeting
11. Cynosure Announces Presentation of 16 Abstracts at 33rd ASLMS Annual Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)... 2015  BioMed Realty Trust, Inc. (NYSE: ... square feet of space in the most dynamic and ... through the termination of Vertex Pharmaceuticals, leases on three ... February 28, 2015. BioMed Realty will receive a $14 ... to reposition the properties to meet the growing demand ...
(Date:3/1/2015)... 2, 2015 LifeScienceIndustryResearch.com announces ... Report of 178 pages along with 8 company ... The 2015 Market Research Report on ... and deep research report on Global Angiographic X-ray ... Angiographic X-ray System basic information including definition, classification, ...
(Date:3/1/2015)... 2015  Patients suffering from chronic plantar fasciitis ... foot ailment, according to research presented at the ... Scientific Meeting . Researchers utilized ultrasound imaging and ... diseased fasciitis tissue. Permanently removing damaged, pain-generating tissue ... its place, restoring normal function. "Plantar ...
Breaking Medicine Technology:BioMed Realty Gets Back 313,000 Square Feet Of Valuable Real Estate In Cambridge Innovation District 2BioMed Realty Gets Back 313,000 Square Feet Of Valuable Real Estate In Cambridge Innovation District 3Global Angiographic X-ray System Industry Research Report 2Global Angiographic X-ray System Industry Research Report 3Global Angiographic X-ray System Industry Research Report 4Global Angiographic X-ray System Industry Research Report 5Interventional radiology treatment relieves chronic plantar fasciitis 2Interventional radiology treatment relieves chronic plantar fasciitis 3
(Date:3/2/2015)... (PRWEB) March 02, 2015 In light ... of anticoagulant Xarelto (rivaroxaban) tablets, Ford & ... may be helpful for future users, but may come ... injuries from taking the drug. The FDA has now ... under Adverse Reactions on Xarelto's label. The term “cytolytic ...
(Date:3/2/2015)... March 02, 2015 ProvidaStaff ... for its educational healthcare division to EDU Healthcare ... healthcare services to school systems and students nationwide. , ... to school districts throughout the country,” said Angela M. ... be a better organization and the introduction of EDU ...
(Date:3/1/2015)... To help healthcare organizations ... practices compliantly and profitably, MDreferralPRO and Vericle ... The interoperability between a strategic referral management ... management system is necessary for a healthcare ... referral management and development solution relies on ...
(Date:3/1/2015)... 2015 Women’s Excellence now offers ... (OAB) symptoms, such as a strong need to urinate with ... medication (anticholinergic) does not work well enough or cannot be ... another approach to targeting the source of OAB, the bladder ... and bladder muscle, blocking the signals that trigger OAB. ...
(Date:3/1/2015)... March 01, 2015 A federal ... http://www.consumerinjurylawyers.com/wright-profemur-hip-replacement ) scheduled to go to trial in ... a witness to provide testimony regarding the role ... of the Profemur device, Bernstein Liebhard LLP comments. ... Court, Northern District of Iowa on February 25th, ...
Breaking Medicine News(10 mins):Health News:Ford & Associates Nationwide Legal Services, A.P.C., Comments on Xarelto Lawsuits Upon FDA Revisions 2Health News:Ford & Associates Nationwide Legal Services, A.P.C., Comments on Xarelto Lawsuits Upon FDA Revisions 3Health News:Ford & Associates Nationwide Legal Services, A.P.C., Comments on Xarelto Lawsuits Upon FDA Revisions 4Health News:ProvidaStaff Announces New Name Change to EDU Healthcare for Its Educational Healthcare Division 2Health News:ProvidaStaff Announces New Name Change to EDU Healthcare for Its Educational Healthcare Division 3Health News:Power Up Physician and Patient Referral Management While Qualifying for ARRA Incentives 2Health News:Power Up Physician and Patient Referral Management While Qualifying for ARRA Incentives 3Health News:Power Up Physician and Patient Referral Management While Qualifying for ARRA Incentives 4Health News:Women's Excellence Now Offers BOTOX For Overactive Bladder Treatment 2Health News:Wright Profemur Hip Lawyers at Bernstein Liebhard LLP Comment on Court’s Decision Regarding Testimony Pertaining to Prototype for Profemur Hip Replacement 2Health News:Wright Profemur Hip Lawyers at Bernstein Liebhard LLP Comment on Court’s Decision Regarding Testimony Pertaining to Prototype for Profemur Hip Replacement 3
... may help reduce unnecessary surgeries in women of reproductive ... study appearing in the February issue of the journal ... of preoperative CT over the past decade, along with ... in negative appendectomies among women 45 years and younger," ...
... WASHINGTON , Jan. 25 Detroit -area ... in a Detroit -area home health care fraud scheme, announced ... U.S. Attorney for the Eastern District of Michigan Barbara L. McQuade; ... Field Office; and Special Agent in Charge Lamont Pugh III of ...
... , , "Was John Brown,s raid on Harpers ... a hero or a villain?" Randall Terry , WICHITA, ... by Randall Terry , Director, Operation Rescue Insurrecta Nex. , Statement ... or condemn Scott Roeder,s actions. That decision will soon rest ...
... "America,s health care problems did not change when the ... need Congress to act on Health Care Reform now", insists Dr. ... focus on the economy and jobs is necessary and proper, however ... health care reform will bring to all Americans.   We must ...
... , Jan. 25 January is almost over and ... spirit of the Holidays, the Phoenix Quest Center is offering the ... development.  This course is a great opportunity to help participants start ... as offering them valuable skills in dealing with social conflicts of ...
... , PHILADELPHIA , Jan. 25 ... defects in humans, affecting 8 per 1000 live births ... early infancy. Increasing numbers of survivors combined with developmental ... led to a growing identification of neurobehavioral symptoms in ...
Cached Medicine News:Health News:Preoperative CT useful for younger women with suspected appendicitis 2Health News:Physical Therapist Pleads Guilty in Connection with Detroit Home Health Care Fraud Scheme 2Health News:Physical Therapist Pleads Guilty in Connection with Detroit Home Health Care Fraud Scheme 3Health News:Scott Roeder Trial: Randall Terry, Operation Rescue Founder and Insurrecta Nex Members to Attend Trial in Wichita 2Health News:National Medical Association Urges Congress to Deliver on Health Care 2Health News:60-Day Free Community Confidence Building and Self-Defense Training 2Health News:Special Bypass Procedure Used During Infant Heart Surgery Does Not Impair Later Neurological Outcomes in Children 2Health News:Special Bypass Procedure Used During Infant Heart Surgery Does Not Impair Later Neurological Outcomes in Children 3
Created to simplify stereopsis screening in children. Based on principles of random dots. No glasses are necessary for this stereo test, and the child's eye movement can be easily observed....
... versatile new test providing the broadest range ... The Multi-Target Stereo test can be used ... stereopsis, visual attention, form and depth perception, ... includes a pair of high quality reversible ...
... These polarized stereo tests provide ... come with a choice of polarized ... thick film lenses slipped into a ... The other choice includes Richmonds new ...
Comes with seven test plates. Red and green glasses filters are mounted in two frames, one for adults and one for children. Suitable for testing very small children as well as adults....
Medicine Products: